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Dedication ((optional)) 
The total syntheses of the neural anti-inflammatory agents guignarderemophilanes C and D have been accomplished for the first time starting 
from g-hydroxy carvone in 15 and 14 steps, respectively. The presented synthetic route proceeds via a known intermediate, whose synthesis 
has been elaborated in our group in the course of the total synthesis of the sesquiterpenoid periconianone A. Key for the successful conversion 
of this intermediate into both targets was finding a suitable strategy to install the 1,2,3-trihydroxylated A-ring scaffold. For this purpose, we 
effectively employed a Mitsunobu inversion, epoxidation, and regioselective epoxide opening sequence, before the bicyclic ring system was 
constructed by an aldol condensation reaction on a sterically demanding substrate. Our reported synthesis set the stage for SAR studies to 
prepare even more potent compounds by modification and derivatization of the natural product’s scaffold. 
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Introduction 
Eremophilane sesquiterpenes present a group of natural products built 
up on a 15-carbon skeleton characterized by a decalin core unit 
connected to two one-carbon substituents at C4 and C5, and an 
isopropenyl or isopropyl group at C7 (Figure 1, A). The first member 
of this family had been isolated and reported by J. L. Simonsen and 
coworkers in 1932, and named eremophilone.[1] Since this discovery, 
many new compounds bearing this structural motif have been 
described, featuring a number of biological activities such as anti-
inflammatory, anti-tumor or anti-bacterial.[2 – 4] Structural diversity for 
eremophilane sesquiterpenes, as for terpenes in general, is generated 
by a variety of oxidation events taking place during biosynthesis. All of 
the 15 carbons are known to be accessible for oxidation, with 
hydroxylation often taking place at C1, C3, C7 and/or C12. However, 
C1,C2,C3-trihydroxylated eremophilanes are rare: besides the two 
target compounds, only four such natural products have been 
described to date, viz. ligumacrophyllatin,[5] sporogen AO-2[6], 1β,8β-
dihydroxy-2β,3α-diangeloyloxyeremophil-7(11)-en-8α(12)-olide,[7] and 
guignarderemophilane F.[8] The former is characterized by an all 
a-configuration of the three hydroxy groups (1a,2a,3a); the second 
by a 1a,2b,3a-configuration; the third by a 1b,2b,3a-configuration; and 
the latter as a stereoisomer of guignarderemophilane C by a 1b,2a,3a-
configuration. Neither of these compounds have been synthesized yet 
and there is no reported preparative strategy addressing this unusual 
trihydroxylated A-ring motif. Recently, two natural products with a 
1a,2b,3b-trihydroxylated scaffold have been isolated for the first time 
from the fungus Guignardia mangiferae, and named guignard-
eremophilanes C (1) and D (2).[9] The fungus Guignardia mangiferae 
is an endosymbiont of plants such as Gelsemium elegans, whose 
extracts are used in traditional Chinese medicine as nervous relaxant 
and for the treatment of pain.[10] Both eremophilanes showed neural 
anti-inflammatory activity by inhibiting the LPS-induced NO production 
in BV2 cells with IC50 values of 6.4 and 4.2 µM, respectively.[9] 
Therefore, guignarderemophilanes C and D may potentially serve as 
lead compounds for developing treatment options for neuro-
degenerative diseases. 
 
Figure 1. A: Eremophilane sesquiterpenes containing a 1,2,3-trihydroxylated A-
ring. B: Retrosynthetic analysis of guignarderemophilanes C (1) and D (2). 
Besides the unusual 1,2,3-trihydroxylated scaffold, another striking 
structural feature of both eremophilane sesquiterpenoids is the 
presence of five contiguous stereogenic centers in the six-membered 
A-ring, one of which is quaternary. Guignarderemophilane C contains 
an additional stereogenic center (C7) connected to an isopropenyl 
moiety with unsaturation in b,g position of the carbonyl group, which is 
prone to isomerize to the a,b-unsaturated ketone, as in 
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guignarderemophilane D. From a retrosynthetic perspective, we 
envisioned to use cyclohexanone derivative 4, whose synthesis has 
been elaborated in our group in the course of the total synthesis of the 
tricyclic sesquiterpenoid periconianone A (3).[11] As a first challenge, 
we addressed the stereoselective installation of the aforementioned 
three hydroxy groups. To this end, we envisioned inversion of the 
stereocenter at C3 by Mitsunobu reaction of cyclohexanone 4, as well 
as a diastereoselective epoxidation and regioselective epoxide 
opening sequence to install the C1 and C2 hydroxy groups. 
Functionalization at C7 to install the three-carbon unit for completion 
of the 15-carbon skeleton was envisioned by an aldol addition of 
acetone, followed by regioselective dehydration. 
In this study, we present the first total syntheses of 
guignarderemophilane C and D starting from g-hydroxy carvone (5) in 
15 and 14 steps, respectively. Additionally, in the course of our 
synthetic endeavor, we observed a spontaneous aldol condensation 
under specific epoxidation reaction conditions. The main challenge 
consisted in finding a suitable sequence for the introduction of the 
functional groups on the carbon skeleton with respect to the 
substitution pattern in the A-ring. Key for the successful synthesis was 
to establish all stereogenic centers in the A-ring before the B-ring was 
constructed by aldol cyclization. 
Results and Discussion 
The synthesis commenced from known enone 4 (Scheme 1),[11] which 
was prepared from g-hydroxy carvone (5) in 29 % yield over four steps: 
TBS protection of the secondary alcohol was followed by a 1,4-
addition of methyl cuprate to the enone, and the formed enol ether was 
trapped with TMSCl to form the silyl enol ether 6. Lewis acid-mediated 
Michael addition on methyl vinyl ketone to install the alkyl group at C5 
was performed with high diastereoselectivity (dr > 10:1). A Criegee 
fragmentation then removed the isopropenyl moiety, used as directing 
group for the stereoselective installation of the substituents at C3, C4 
and C5, to give enone 4. 
 
Scheme 1. Synthesis of the previously reported precursor 4. 
We had at first envisioned the synthesis to proceed by epoxidation of 
the C1=C2 double bond of enone 4, followed by an aldol condensation 
to form the octalone core 7 (Scheme 2). While screening conditions 
for the epoxidation, we found diverging diastereoselectivities for 
different peroxide sources: with hydrogen peroxide,[12][13] epoxidation 
on the same face as the OTBS group in the A-ring was observed and 
we isolated epoxy ketones 8 and 9 with a dr of 3:1. Using tert-butyl 
hydrogen peroxide, the epoxidation exclusively took place (dr > 10:1) 
on the opposite face with respect to the OTBS group. Observations for 
similar substrates with comparable stereochemical outcome have 
already been described in the literature.[14][15] Although the obtained 
selectivities cannot be fully explained based on steric or 
stereoelectronic effects or both, it might be reasonable to argue that 
the attack for the sterically more demanding tert-butyl hydrogen 
peroxide preferably takes place from the less shielded face of the six-
membered ring at C2 of 4 with the OTBS group in a pseudoequatorial 
position. However, applying the described conditions for the latter 
reaction, instead of the epoxy ketone, we observed spontaneous 
closure of the B-ring to form the octalone 10 (Scheme 2, A). To the 
best of our knowledge, this is the first reported example of a tandem 
epoxidation–aldol condensation sequence. After work-up of the 
reaction mixture, the 1H NMR spectrum of the crude product indicated 
formation of octalone 10 and an unknown compound in a ratio of 4:1. 
When the reaction time was decreased from five hours to one hour, 
the ratio of the two products increased to 2:3 in favor of the unknown 
compound. This byproduct was identified to be the bicyclic g,d-epoxy 
b-hydroxy ketone by isolation and structure elucidation based on 
2D NMR spectra. Therefore, we hypothesize epoxidation taking place 
prior to aldol addition to form the isolated intermediate, which can 
subsequently undergo dehydration to form octalone 10. An aldol 
addition, epoxidation and dehydration pathway is less likely, since the 
electron rich C1=C2 double bond of the hypothetically formed bicyclic 
aldol addition product would not undergo epoxidation under the given 
reaction conditions. Additionally, the intermediacy of g,d-epoxy b-
hydroxy ketone rules out a pathway in which nucleophilic epoxidation 
takes place after aldol condensation in a 1,6-fashion to the dienone 
system. Cyclization of epoxy ketone 8 (major diastereoisomer) 
provided access to the other octalone diastereoisomer 7.[16] The 
absolute configuration of both epoxy ketones 8 and 9 as well as 
octalones 7 and 10 could not be established by NOESY NMR 
spectroscopy. Therefore, we performed reductive cleavage of epoxy 
ketone 8 to give b-hydroxy ketone 11 using the reactive species 
Na[PhSeB(OEt)3] prepared in situ from (SePh)2, NaBH4 and AcOH in 
CH2Cl2/EtOH (Scheme 2, B).[17][18] NOESY NMR spectroscopy showed 
correlations of H1ax to H2, H3 and H15; of H2 to both H1ax and H1eq; 
of H3 to H1ax, H2, H14 and H15 (Scheme 2, C). Coupling constants 
for the proton signals at positions C1, C2, C3 and C4 (3JH1ax-H2eq = 
3.5 Hz; 3JH1eq-H2eq = 3.7 Hz; 3JH2eq-H3ax = 2.7 Hz; 3JH3ax-H4ax = 10.0 Hz) 
further corroborated the assignment of the absolute configuration at 
stereogenic center C2 of 11, and hence provided substantial evidence 
for the configurational assignment of intermediates 7, 8, 9 and 10 
obtained after epoxidation. 
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Scheme 2. A: Epoxidation of enone 4 and tandem epoxidation/aldol 
condensation approach; B: Reductive cleavage of epoxy ketone 8 to b-hydroxy 
ketone 11; C: Key NOESY correlations for the configurational assignment of the 
C2 hydroxy group in 11; D: Investigation of the Mitsunobu reaction of epoxy 
ketone 12. 
However, epoxy alcohol 12 was found completely unreactive towards 
Mitsunobu reaction conditions (up to 150°C under microwave 
irradiation)[19][20] and did not form the ester 13 after the TBS-protecting 
group in 8 had been removed (Scheme 2, D). Therefore, we decided 
to use a route which addresses the inversion of the configuration at 
C3 first. TBS deprotection of enone 4 with aqueous HF in MeCN 
already set the stage for the Mitsunobu reaction. No conversion was 
monitored applying standard Mitsunobu protocols using PPh3, DIAD 
and acetic acid as nucleophile.[19][20] It is well documented in literature 
that acetic acid can react sluggishly in the Mitsunobu reaction.[21] 
Therefore, we decided to investigate the reaction using the more 
suitable nucleophile para-nitrobenzoic acid. Key for the successful 
transformation was to use Volante’s method,[22] a modified Mitsunobu 
procedure, which involves mixing of PPh3 and DIAD first before adding 
the alcohol 14 and the acid to the reaction mixture at 0°C. After the 
mixture was warmed up to room temperature and stirred for 35 min, 
heating in the microwave at 60°C for one hour led to formation of the 
ester 15 with full inversion at C3 and 92 % yield over two steps 
(Scheme 3). Conditions used earlier for the tandem epoxidation and 
aldol reaction of enone 4 did not result in the transformation of enone 
15 to its desired epoxy octalone. Fortunately, aldol cyclization of the 
ester 15 via an intermediate enamine upon reaction with pyrrolidine in 
the presence of AcOH furnished the doubly unsaturated octalone 16 
in 61 % yield. There are only few literature reports on the epoxidation 
of g,d-unsaturated octalones, and unfortunately, the C1=C2 double 
bond could not be epoxidized by mCPBA.[23] However, we succeeded 
to form the epoxide of monocyclic 15. Epoxidation of electron-poor 
double bonds is usually conducted under basic conditions using a 
nucleophilic peroxide reagent. With the base-sensitive ester moiety at 
C3, a functional group necessary in the envisioned regioselective 
epoxide opening (17 à 18), we tried to find conditions avoiding 
hydrolysis of this ester. We were able to optimize the yield of the 
epoxidation reaction up to 82 % in favor of epoxy ketone 13 with an 
intact ester group on a small scale using Na2CO3 and H2O2 in an 
acetone/H2O mixture.[24][25] However, we observed longer reaction 
times and decreased yields on a larger scale. After extensive 
screening, best results in terms of conversion to both epoxy ketones 
13 and 19 were obtained by a reagent combination of triton B and H2O2 
in THF at 0°C, which led to formation of the two compounds in a 
combined yield of 78 % (19/13 5:2). The secondary hydroxy group of 
hydrolyzed epoxy ketone 13 was acetylated using standard reaction 
conditions (Ac2O, NEt3, DMAP) to give the acetoxy epoxide 20 in 88 % 
yield. With the aim to minimize the use of protecting groups, we 
continued by cyclizing the B-ring of epoxy ketone 20 and envisioned 
epoxide opening at a later stage. Unfortunately, neighboring group-
assisted hydrolysis[14][15][26] on the octalone intermediate 17 resulted in 
formation of a complex mixture. 
 
Scheme 3. Inversion of the hydroxy group at C3 in 14 by a Mitsunobu reaction, 
construction of the B-ring and attempted hydrolysis of the epoxide in 17. 
Therefore, we designed an approach with the aim to first complete the 
substitution pattern on the A-ring using protecting groups for the 
hydroxy functions at C1 and C2. Regioselective epoxide opening was 
triggered by treatment of 20 with the Lewis acid BF3·OEt2 to form the 
desired triol 21 in 93 % yield (Scheme 4). Scaling up this reaction from 
10 mg to >100 mg turned out to be problematic: the required reaction 
time was much longer (seven hours instead of two hours) and the yield 
dropped to 43 %. With 21 in hand, the next challenge was to find 
appropriate protecting groups for the anti-diol at C1 and C2. Ideally, 
these protecting groups would be cleavable under identical reaction 
conditions with respect to the conditions needed for cleavage of the 
acetyl group. Another aspect was to strive for very mild deprotection 
conditions as to avoid isomerization of the isopropenyl group to be 
installed in subsequent steps of the synthesis. Being aware that the 
C2 hydroxy function in b-position to the carbonyl group was prone to 
elimination, we initially investigated the introduction of acetyl and 
benzoyl protecting groups on the anti-diol at C1/C2. However, 
elimination of acetic acid or benzoic acid was observed in both the 
protection and the following aldol cyclization steps. Acetylation of 21 
using Ac2O, NEt3 and DMAP furnished a mixture of the desired fully 
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acetylated triol 22 (44 %) and elimination product 23 (5:1). 
Benzoylation of 21 by BzCl, NEt3 and DMAP gave only 22 % yield of 
the desired dibenzoylated product 24. For both 22 and 24, cyclization 
using pyrrolidine and AcOH resulted in partial elimination of the C2 
acetyl (3:1 mixture of 25 and 26) or C2 benzoyl (2:1 mixture of 27 and 
28) groups, respectively. Unsatisfactory results were also obtained for 
the cyclization attempts using the unprotected diol 21, resulting in 
decomposition without formation of octalone 18. Only mono-protection 
at either the C1 or the C2 hydroxy groups was observed in the reaction 
with TBSCl to form silyl ethers 29 and 30 (3:1) in a combined yield of 
91 %. Attempted removal of the acetyl group at C3 with the goal to 
install silicon-based protecting groups for all three hydroxy 
substituents only gave a complex mixture instead of unprotected triol. 
 
Scheme 4. A: Regioselective hydrolysis of the epoxide in 20. B: Attempted 
strategies with protecting groups on the C1/C2 diol. 
The reagent TIPDSCl2, widely applied in carbohydrate chemistry for 
the protection of 1,2- and 1,3-diols,[27][28] was found suitable for our 
substrate, and the fully protected triol 31 was isolated in 69 % yield 
(Scheme 5). The following aldol condensation reaction with substrate 
31 via an enamine intermediate generated by reaction with pyrrolidine 
in the presence of AcOH was successful (see Scheme 2), and both 
conversion and yield were further improved by changing the solvent 
from CH2Cl2 to the more apolar toluene to form octalone 32 in 68 % 
yield. Despite the steric demand of the TIPDS group and the imparted 
increase in rigidity of the A-ring due its fusion to an additional seven-
membered silyloxy ring, intramolecular aldol addition to the ketone at 
C10 still took place. Studying the structure of the aldol addition 
intermediate (Scheme 5), it is discernible that the bottom face of the 
A-ring is not overly shielded from the TIPDS group in pseudo-
equatorial orientation. Upon elimination of water, we now had octalone 
32 in hand and addressed the installation of the isopropenyl group for 
targeting the sesquiterpene skeleton. Similar procedures on octalones 
using a two-step procedure have already been described in 
literature:[29 – 32] first, aldol addition to acetone gives the tertiary alcohol, 
which is then dehydrated regioselectively using Burgess 
reagent.[33 – 35] For the aldol step, we had to slightly modify the literature 
procedure and add the acetone to the enolate at –40°C, as previous 
experiments had shown no conversion and full recovery of starting 
material when the electrophile was added at –78°C. In case of our 
substrate, the seven-membered ring of the TIPDS group influences 
the conformation of the A- and B-ring and might thus lower the 
reactivity of the enolate formed by deprotonation of 32. Upon 
modification of the known procedure, we isolated the desired tertiary 
alcohol 33 in an acceptable yield of 67 % with full diastereoselectivity. 
 
Scheme 5. Construction of the B-ring and endgame in the synthesis of 
guignarderemophilanes C (1) and D (2). 
To complete the installation of the three-carbon side chain, regio-
selective elimination of water from 33 was achieved by treatment with 
Burgess reagent to give the isopropenylated octalone 34 as the 
desired elimination product in a modest yield of 54 %. Using triflic 
anhydride and DIPEA[32] instead of the milder Burgess reagent 
resulted in the formation of a complex mixture. Having all substituents 
installed, the endgame of the synthesis had to be addressed by 
deprotection of both the TIPDS and acetyl groups. With a combination 
of CsF and ammonia in methanol at 50°C,[36] all protecting groups were 
cleaved. However, formation of guignarderemophilane C (1) was not 
observed, as the alkaline reaction conditions turned out to effect 
isomerization of the C=C double bond of the isopropenyl group to 
provide guignarderemophilane D (2) instead. Therefore, in order to 
avoid isomerization and to give access to guignarderemophilane C (1), 
a milder two-step procedure was developed. Compound 34 was 
treated with TBAF as fluoride anion source to cleave the TIPDS group 
and after work-up, the acetyl group was removed by reaction with 
ammonia in methanol at room temperature. Both natural products 
were obtained after evaporation of the solvent and the ratio of the two 
natural product isomers slightly increased to 4.6:1 (1/2) in favor of 2 
upon purification by flash column chromatography. Complete 
separation of the isomers was accomplished by reversed-phase HPLC 
O
O
AcO
OH
HO
21, 93 % (43 %)
O
O
O
O BF3
O
BF3·OEt2
toluene, 0°C
O
O
AcO
O
21
O
O
AcO
OR
for a) 23 R = Ac
22/23 5:1 (1H NMR)
a) Ac2O, NEt3
DMAP, CH2Cl2, rt
or
b) BzCl, NEt3
DMAP, CH2Cl2, rt
AcO
OR
RO
25 R = Ac
pyrrolidine
AcOH
CH2Cl2, rt
O
AcO
OR
26 R = Ac
25/26 3:1 (1H NMR) 
28 R = Bz
27/28 2:1 (1H NMR)
OO
O
AcO
OR
RO
for a) 22 R = Ac, 44 %
for b) 24 R = Bz, 22 %
21
29, 67 %
TBSCl, imidazole
DMAP, CH2Cl2, rt
A
B
20
O
O
AcO
OTBS
HO
+
+
27 R = Bz
30, 24 %
O
O
AcO
OH
TBSO
+
10
O
O
AcO
O
SiO
Si
O
34, 54 % Guignarderemophilane C (1)72 % over two steps
21
31, 69 %
TIPDSCl2, imidazole
CH2Cl2, rt
pyrrolidine, AcOH
toluene, rt
32, 68 %
Guignarderemophilane D (2)
70 %
NH3 (7 M), CsF
MeOH, rt to 50°C
NaOMe
MeOH, 0°C
LHMDS, ZnCl2, THF, –78°C
then Me2CO, –40°C
Burgess reagent
toluene, rt
OO
Si
Si
O O
Me
MeO
HHH
O
OO
Si
Si
O O
Me
MeO
HHH
O
OO
Si
Si
O O
Me
MeO
HHH
O
HO
HO
OH
Me
MeO
HHH
H
H
OH
H 1. TBAF, THF, 0°C
2. NH3, MeOH, 0°C
HO
HO
OH
Me
MeO
HHH
33, 67 %
OO
Si
Si
O O
Me
HHH
O
HO
O
Me
HELVETICA 
5 
resulting in pure guignarderemophilane C (1) and 
guignarderemophilane D (2). Alternatively, guignarderemophilane D 
(2) was obtained from its isomer guignarderemophilane C (1) by 
treatment with NaOMe in MeOH at 0°C in 70 % yield. The NMR 
spectra (1H and 13C) of both the synthetic compounds were in 
agreement with those reported for the isolated natural products,[9] but 
for the optical rotation values we observed substantial differences and 
opposite signs for both compounds: our measured optical rotation 
value for guignarderemophilane C was [𝛼]$%& = +35° (c = 0.88, MeOH) 
and the reported value [𝛼]$%'= –175° (c = 0.01, MeOH). The values for 
guignarderemophilane D were [𝛼]$%& = +38° (c = 0.70, MeOH) for the 
synthetic and [𝛼]$%' = –121° (c = 0.12, MeOH) for the isolated material. 
In order to provide evidence for the identity of the isolated natural 
products and the synthetic material, we measured a CD spectrum of 
synthesized 1, which showed to be in agreement with the one reported 
in literature (see supporting information, figure S4). 
Conclusion 
In conclusion, we present the first total synthesis of the 
polyoxygenated eremophilane-type sesquiterpenes guignard-
eremophilane C (1) and D (2) by applying a concise route starting from 
known intermediate 4. Both syntheses have been achieved in eleven 
and ten steps, respectively. Installation of the three hydroxy groups in 
the A-ring was identified as a key challenge, which was successfully 
tackled by applying a Mitsunobu inversion, epoxidation and 
regioselective hydrolysis of the epoxide with neighboring-group 
participation. In order to find more potent neural anti-inflammatory 
active agents, derivatization of both the natural products and synthetic 
intermediates is envisioned. 
 
Experimental Section 
General Aspects and Materials 
All chemicals have been purchased from Acros, Alfa Aesar, 
Fluorochem or Sigma-Aldrich and were used without further 
purification (except for Et3N, which was freshly distilled before use). All 
reactions have been carried out in flame-dried glassware (unless 
aqueous reagents were used) and reactions involving air sensitive 
compounds have been performed under an argon or nitrogen 
atmosphere. Solvents applied for chemical transformations were 
either anhydrous quality or HPLC grade solvents, which have been 
dried by filtration through activated aluminum oxide under nitrogen 
(H2O content <10 ppm, Karl-Fischer titration). For work-up and 
purification, solvents have been distilled from technical grade. All 
synthetic transformations have been monitored by either thin layer 
chromatography (TLC) or 1H NMR spectroscopy. Yields refer to 
purified, dried and spectroscopically pure compounds. TLC was 
performed on Merck silica gel 60 F254 plates (0.25 mm thickness) pre-
coated with a fluorescent indicator. Concentration under reduced 
pressure was performed by rotary evaporation at 40°C or by 
lyophilization. Flash chromatography was performed using silica gel 
60 (230-400 mesh) from Sigma-Aldrich with a forced flow eluent at 
0.1–0.3 bar pressure. High-performance liquid chromatography 
(HPLC) was performed by using an Agilent 1100 series instrument 
equipped with reversed-phase columns for analytical separation 
(Synergi Hydro-RP, 4 μm, 80 Å, 150 mm x 4.6 mm, Phenomenex) or 
semi-preparative separation (Synergi Hydro-RP, 10 μm, 80 Å, 
150 mm x 10.0 mm, Phenomenex). All 1H and 13C NMR spectra were 
recorded using a Bruker 400 MHz (Avance II) or 500 MHz (Avance II 
or III) (1H) & 101 MHz or 126 MHz (13C) spectrometer at room 
temperature (unless otherwise stated). Chemical shifts (δ-values) are 
reported in ppm, spectra were calibrated relative to the residual proton 
chemical shifts (CHCl3, δ = 7.26; MeOD-d3, δ = 3.31) and carbon 
chemical shifts (CDCl3, δ = 77.16; MeOD-d4, δ = 49.00) of the solvents; 
multiplicity is reported as follows: s = singlet, d = doublet, t = triplet, q 
= quartet, m = multiplet or unresolved and coupling constant J is given 
in Hz. IR spectra were recorded on a Perkin Elmer SpectrumTwo ATR-
FTIR. The absorptions are reported in cm−1. All mass spectra (HRMS-
ESI) were recorded by the Mass Spectrometric Service of the 
University of Zurich on a QExactive instrument (Thermo Fisher 
Scientific, Bremen, Germany) equipped with a heated electrospray 
(ESI) ionization source and connected to a Dionex Ultimate 3000 
UHPLC system. Melting points (M.p.) were determined using a Büchi 
B-545 apparatus in open capillaries and are uncorrected. Optical 
rotations °[𝛼]$)  were measured at the sodium D line using a 1 mL cell 
with 1 dm path length, or a 0.2 mL cell with 0.1 dm path length on a 
Jasco P-2000 digital polarimeter and the concentration c is given in 
g/100 mL CHCl3 or MeOH. CD spectra were acquired on a JASCO J-
810 spectrometer. 
(1aR,2S,3R,3aR,7bR)-2-((tert-butyldimethylsilyl)oxy)-3,3a-
dimethyl-1a,3,3a,4,5,7b-hexahydronaphtho[1,2-b]oxiren-6(2H)-
one (7): A mixture of a,b-epoxy ketone 8 (8.5 mg, 25 µmol, 1.0 eq.), 
pyrrolidine (4 μL, 50 µmol, 2.0 eq.) and acetic acid (3 μL, 50 µmol, 
2.0 eq.) in CH2Cl2 (0.5 mL) was stirred for 2 h 20 min at rt, before it 
was quenched by addition of 0.1 M HCl and diluted with CH2Cl2. The 
layers were separated and the aqueous layer was extracted with Et2O 
(3 x). The combined organic layers were dried over Na2SO4, filtered 
and the solvent was removed under reduced pressure. The crude 
material was subjected to flash column chromatography 
(pentane/Et2O 3:1) to give the epoxy octalone 7 (5.9 mg, 18 µmol, 
73 %) as a colorless solid. 
M.p. = 76.2 – 77.5°C. TLC: Rf = 0.34 (SiO2, pentane/Et2O 1:1). [𝛼]$%* = 
+30.7° (c = 0.36, CHCl3). FTIR (neat): ν, = 2954, 2928, 2856, 1682, 
1472, 1258, 1084, 855, 836, 775 cm−1. 1H NMR (500 MHz, CDCl3) δ = 
6.14 (s, 1H), 3.89 (dd, J = 10.0, 1.8 Hz, 1H), 3.56 (d, J = 3.7 Hz, 1H), 
3.46 (dd, J = 3.7, 1.8 Hz, 1H), 2.52 (ddd, J = 18.1, 14.1, 5.5 Hz, 1H), 
2.47 – 2.40 (m, 1H), 1.97 (ddd, J = 13.4, 5.4, 2.3 Hz, 1H), 1.75 (td, J 
= 13.8, 5.5 Hz, 1H), 1.66 (dq, J = 10.0, 6.9 Hz, 1H), 1.04 (s, 3H), 0.96 
(d, J = 7.0 Hz, 3H), 0.94 (s, 9H), 0.17 (s, 3H), 0.14 (s, 3H). 13C NMR 
(126 MHz, CDCl3) δ = 198.4, 161.2, 131.1, 71.4, 56.1, 54.7, 38.2, 37.7, 
34.1, 33.5, 26.0, 18.3, 17.1, 9.7, -3.8, -4.4. HRMS (ESI) Exact mass 
calculated for C18H31O3Si+ [M+H]+: 323.20370, found: 323.20360. 
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(1S,3R,4R,5S,6R)-5-((tert-butyldimethylsilyl)oxy)-3,4-dimethyl-3-
(3-oxobutyl)-7-oxabicyclo[4.1.0]heptan-2-one (8) and 
(1R,3R,4R,5S,6S)-5-((tert-butyldimethylsilyl)oxy)-3,4-dimethyl-3-
(3-oxobutyl)-7-oxabicyclo[4.1.0]heptan-2-one (9): To a solution of 
enone 4 (53.5 mg, 0.16 mmol, 1.0 eq.) in H2O2 (30 % in H2O, 1.55 mL, 
16.5 mmol, 100 eq.) and THF (3.0 mL) at 0°C was added Triton B 
(40 % in MeOH, 90 µL, 0.19 mmol, 1.2 eq). The reaction mixture was 
stirred for 5 h 45 min at that temperature and then quenched by 
addition of sat. aq. NH4Cl solution. The aqueous mixture was extracted 
with Et2O (3 x) and the combined organic layers were dried over 
Na2SO4, filtered and concentrated under reduced pressure. The 
residue was subjected to flash column chromatography (pentane/Et2O 
5:1) to give the a,b-epoxy ketones 8 (26 mg, 76 µmol, 46 %) and 9 
(8.3 mg, 0.024 mmol, 15 %) both as colorless oils. 
a,b-Epoxy ketone 8: TLC: Rf = 0.34 (SiO2, pentane/Et2O 5:1). Optical 
rotation: [𝛼]$%-  = –112.9° (c = 0.40, CHCl3). FTIR (neat): ν,  = 2956, 
2931, 2857, 1714, 1472, 1362, 1256, 1083, 860, 838, 776 cm−1. 1H 
NMR (500 MHz, CDCl3) δ = 3.90 (dd, J = 10.1, 1.0 Hz, 1H), 3.50 (d, J 
= 4.0 Hz, 1H), 3.31 (d, J = 4.0 Hz, 1H), 2.34 (ddd, J = 16.8, 11.5, 4.8 
Hz, 1H), 2.21 (ddd, J = 17.4, 11.4, 4.7 Hz, 1H), 2.14 – 2.08 (m, 1H), 
2.11 (s, 3H), 2.00 (ddd, J = 14.3, 11.5, 4.7 Hz, 1H), 1.65 (ddd, J = 14.3, 
11.4, 4.9 Hz, 1H), 0.94 (s, 9H), 0.92 (s, 3H), 0.91 (d, J = 7.0 Hz, 3H), 
0.16 (s, 3H), 0.13 (s, 3H). 13C NMR (151 MHz, CDCl3) δ = 208.1, 208.1, 
70.6, 57.7, 55.5, 49.0, 38.6, 32.9, 30.1, 29.9, 25.9, 20.2, 18.2, 10.9,  
-3.9, -4.5. HRMS (ESI) Exact mass calculated for C18H33O4Si+ [M+H]+: 
341.21426, found: 341.21431. 
a,b-Epoxy ketone 9: TLC: Rf = 0.40 (SiO2, pentane/Et2O 5:1). [𝛼]$%* = +14.6° (c = 0.26, CHCl3). FTIR (neat): ν,	 = 2955, 2930, 2894, 
2858, 1712, 1258, 1084, 876, 837, 777 cm−1. 1H NMR (400 MHz, 
CDCl3) δ = 4.01 (d, J = 7.2 Hz, 1H), 3.44 (dd, J = 3.5, 0.7 Hz, 1H), 3.25 
(dd, J = 3.6, 0.9 Hz, 1H), 2.38 (ddd, J = 16.3, 11.1, 4.8 Hz, 1H), 2.25 
(ddd, J = 16.8, 11.0, 4.9 Hz, 1H), 2.13 (s, 3H), 1.99 (ddd, J = 14.3, 
11.0, 4.9 Hz, 2H), 1.85 (p, J = 7.1 Hz, 1H), 1.66 (ddd, J = 14.3, 11.1, 
4.9 Hz, 1H), 1.08 (s, 3H), 0.97 (d, J = 7.0 Hz, 3H), 0.94 (s, 9H), 0.18 
(s, 3H), 0.14 (s, 3H). 13C NMR (151 MHz, CDCl3) δ = 208.4 (2C), 70.4, 
61.5, 54.1, 47.6, 44.0, 38.5, 30.5, 30.1, 25.9, 19.4, 18.2, 13.7, -4.3, -
4.7. HRMS (ESI) Exact mass calculated for C18H33O4Si+ [M+H]+: 
341.21426 found: 341.21428. 
(1aS,2S,3R,3aR,7bS)-2-((tert-butyldimethylsilyl)oxy)-3,3a-
dimethyl-1a,3,3a,4,5,7b-hexahydronaphtho[1,2-b]oxiren-6(2H)-
one (10): To a solution of TBS-protected enone 4 (21.0 mg, 65 µmol, 
1.0 eq.) in THF (1.0 mL) at –10°C were added TBHP (5.5 M in decane, 
59 µL, 0.32 mmol, 5.0 eq.) and Triton B (40 % in MeOH, 35 µL, 
78 µmol, 1.2 eq.). The reaction mixture was stirred for 5 h and 15 min 
at –10°C and then quenched by addition of sat. aq. NH4Cl solution. 
The aqueous mixture was extracted with Et2O (3 x) and the combined 
organic layers were dried over Na2SO4, filtered and concentrated. The 
crude material was purified twice by flash column chromatography 
(pentane/Et2O 5:1) to give epoxy octalone 10 (8.2 mg, 25 µmol, 39 %) 
as a colorless solid.  
M.p. = 107.4 – 110.1°C. TLC: Rf = 0.48 (SiO2, pentane/Et2O 5:1). [𝛼]$%- 
= –39° (c = 0.36, CHCl3). FTIR (neat): ν, = 2954, 2930, 2885, 2858, 
1686, 1472, 1258, 1086, 1065, 865, 837, 776 cm−1. 1H NMR (500 MHz, 
CDCl3) δ = 6.16 (s, 1H), 3.76 (d, J = 9.9 Hz, 1H), 3.48 (d, J = 3.6 Hz, 
1H), 3.44 (d, J = 3.6 Hz, 1H), 2.57 (ddd, J = 17.6, 14.9, 5.0 Hz, 1H), 
2.41 (d, J = 17.4 Hz, 1H), 1.99 – 1.95 (m, 1H), 1.68 (td, J = 14.1, 4.5 
Hz, 1H), 1.44 (dd, J = 9.8, 6.7 Hz, 1H), 1.15 (s, 3H), 0.97 (d, J = 6.7 
Hz, 3H), 0.94 (s, 9H), 0.19 (s, 3H), 0.14 (s, 3H). 13C NMR (126 MHz, 
CDCl3) δ = 198.3, 161.8, 129.6, 70.1, 61.9, 56.5, 47.7, 36.7, 35.8, 33.9, 
25.9, 18.1, 17.2, 11.7, -4.1, -4.7. HRMS (ESI) Exact mass calculated 
for C18H31O3Si+ [M+H]+: 323.20370, found: 323.20356. 
(2R,3R,4S,5R)-4-((tert-butyldimethylsilyl)oxy)-5-hydroxy-2,3-
dimethyl-2-(3-oxobutyl)cyclohexan-1-one (11): Stock solution: To a 
solution of diphenyl diselenide (89.5 mg, 287 mmol) in EtOH (1.0 mL) 
were added NaBH4 (16.7 mg, 573 mmol) and acetic acid (4.0 µL), and 
the mixture was stirred at rt for 20 min to form a yellow solution.  
a,b-Epoxy ketone 8 (13.0 mg, 38.0 µmol, 1.0 eq.) was dissolved in 
CH2Cl2 (0.2 mL) and the prepared stock solution (0.2 mL, 57 µmol, 
1.5 eq) was added over a period of 5 min at rt. The reaction mixture 
turned yellow and was stirred for 1 h 10 min, before it was diluted with 
CH2Cl2 and brine. The layers were separated and the aqueous layer 
was extracted with CH2Cl2 (3 x). The combined organic layers were 
dried over Na2SO4, filtered and concentrated under reduced pressure. 
The residue was subjected to flash column chromatography 
(pentane/Et2O 1:1) to give the b-hydroxy ketone 11 (5.6 mg, 16 µmol, 
43 %) as a colorless oil. 
TLC: Rf = 0.50 (SiO2, pentane/Et2O 1:3). [𝛼]$%-  = +21.8° (c = 0.28, 
CHCl3). FTIR (neat): ν, = 3493, 2955, 2929, 2857, 1711, 1463, 1254, 
1067, 837, 776 cm−1. 1H NMR (500 MHz, CDCl3) δ = 4.08 (q, J = 3.4 
Hz, 1H), 3.82 (dd, J = 10.0, 2.7 Hz, 1H), 2.69 (ddd, J = 15.3, 3.4, 2.2 
Hz, 1H), 2.57 (dd, J = 15.4, 3.6 Hz, 1H), 2.50 (ddd, J = 17.3, 11.2, 4.5 
Hz, 1H), 2.40 (dd, J = 2.2, 1.0 Hz, 1H), 2.28 (ddd, J = 16.9, 11.1, 4.9 
Hz, 1H), 2.17 – 2.08 (m, 1H), 2.14 (s, 3H), 1.97 (ddd, J = 14.3, 11.2, 
4.5 Hz, 1H), 1.04 (s, 3H), 1.61 (ddd, J = 14.2, 11.1, 4.9 Hz, 1H), 0.96 
(d, J = 6.9 Hz, 3H), 0.93 (s, 9H), 0.14 (s, 3H), 0.13 (s, 3H). 13C NMR 
(126 MHz, CDCl3) δ = 212.0, 209.0, 74.2, 71.5, 50.2, 42.5, 38.8, 36.4, 
30.2, 28.7, 26.0, 20.6, 18.2, 11.7, -4.1, -4.4. HRMS (ESI) Exact mass 
calculated for C18H35O4Si+ [M+H]+: 343.22991, found: 343.22956. 
(1S,3R,4R,5S,6S)-5-hydroxy-3,4-dimethyl-3-(3-oxobutyl)-7-oxabi-
cyclo[4.1.0]heptan-2-one (12): To a solution of a,b-epoxy ketone 8 
(9.0 mg, 26 µmol, 1.0 eq.) in MeCN (0.5 mL) was added HF (48 % in 
H2O, 5 µL, 0.26 mmol, 10 eq.). The mixture was stirred for 3 h 15 min 
at rt before it was quenched by addition of sat. aq. NaHCO3. The 
mixture was extracted with Et2O (3 x) and the combined organic layers 
were washed with H2O, dried over Na2SO4, filtered and concentrated. 
The residue was purified by flash column chromatography 
(pentane/Et2O 1:3 to 1:5 to 1:7) to afford the epoxy alcohol 12 (3.9 mg, 
17 µmol, 65 %) as a colorless oil. 
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TLC: Rf = 0.50 (SiO2, Et2O). 1H NMR (400 MHz, CDCl3) δ = 3.89 (ddd, 
J = 10.0, 8.6, 1.2 Hz, 1H), 3.67 (dd, J = 4.0, 1.1 Hz, 1H), 3.39 (d, J = 
4.0 Hz, 1H), 2.40 – 2.18 (m, 2H), 2.12 (s, 3H), 2.09 – 1.94 (m, 2H), 
1.78 (d, J = 8.6 Hz, 1H), 1.66 (ddd, J = 14.3, 10.5, 5.6 Hz, 1H), 1.02 
(d, J = 6.8 Hz, 3H), 0.94 (s, 3H). 13C NMR (126 MHz, CDCl3) δ = 207.9, 
207.2, 70.2, 57.3, 55.6, 49.1, 38.6, 33.3, 30.1, 29.4, 20.0, 10.4. HRMS 
(ESI) Exact mass calculated for C12H18O4Na+ [M+Na]+: 249.10973, 
found: 249.10979. 
(4R,5R,6R)-4-hydroxy-5,6-dimethyl-6-(3-oxobutyl)cyclohex-2-en-
1-one (14): To a solution of TBS protected alcohol 4 (792 mg, 
2.44 mmol, 1.0 eq.) in MeCN (36 mL) was added HF (48 % in H2O, 
1.0 mL, 24.4 mmol, 10 eq.). The mixture was stirred for 38 h at rt, 
before it was quenched by addition of sat. aq. NaHCO3. The solution 
was extracted with Et2O (3 x) and the combined organic layers were 
washed with H2O, dried over Na2SO4, filtered and concentrated. The 
crude material was subjected to flash column chromatography (Et2O) 
to yield the allylic alcohol 14 (471 mg, 2.24 mmol, 92 %) as a colorless 
solid.  
M.p. = 78.8 – 83.5°C. TLC: Rf = 0.38 (SiO2, Et2O). [𝛼]$%- = –63.6° 
(c = 0.48, CHCl3). FTIR (neat): ν,  = 3472, 2971, 2020, 1713, 1672, 
1377, 1041 cm−1. 1H NMR (400 MHz, CDCl3) δ = 6.82 (dd, J = 10.3, 
2.0 Hz, 1H), 5.92 (dd, J = 10.2, 2.2 Hz, 1H), 4.22 (ddt, J = 9.4, 7.2, 2.1 
Hz, 1H), 2.33 (ddd, J = 15.1, 11.3, 4.2 Hz, 1H), 2.27 – 2.19 (m, 1H), 
2.19 – 2.09 (m, 1H), 2.14 (s, 3H), 1.96 (dq, J = 9.5, 6.7 Hz, 1H), 1.84 
(d, J = 7.2 Hz, 1H), 1.62 (ddd, J = 14.0, 11.3, 4.1 Hz, 1H), 1.11 (d, J = 
6.8 Hz, 3H), 1.02 (s, 3H). 13C NMR (126 MHz, CDCl3) δ = 208.8, 203.2, 
150.7, 127.9, 70.6, 48.5, 42.8, 38.5, 30.0, 28.4, 19.3, 10.8. HRMS 
(ESI) Exact mass calculated for C12H19O3+ [M+H]+: 211.13287, found: 
211.13286. 
(1S,5R,6R)-5,6-dimethyl-4-oxo-5-(3-oxobutyl)cyclohex-2-en-1-yl 
4-nitrobenzoate (15): Triphenylphosphine (517 mg, 1.95 mmol, 
2.0 eq.) and DIAD (383 µL, 1.95 mmol, 2.0 eq.) were dissolved in THF 
(4.5 mL) at 0°C. After 5 min allylic alcohol 14 (205 mg, 0.98 mmol, 
1.0 eq.) in THF (7.5 mL) and 4-nitrobenzoic acid (329 mg, 1.95 mmol, 
2.0 eq.) were added to the reaction mixture. After stirring was 
continued for 5 min at 0°C, the reaction mixture was allowed to warm 
up to rt and was stirred for 35 min, before it was heated to 60°C for 1 h 
in the microwave. After evaporation of the solvent, the crude material 
was subjected to flash column chromatography (pentane/Et2O 1:1) to 
give the ester 15 (345 mg, 0.98 mmol, quant.) as a colorless solid. 
M.p. = 72.6 – 74.6°C. TLC: Rf = 0.25 (SiO2, pentane/Et2O 1:1). [𝛼]$%- = 
+159.2° (c = 0.47, CHCl3). FTIR (neat): ν, = 2982, 1723, 1682, 1528, 
1348, 1270, 1102, 1066 cm−1. 1H NMR (500 MHz, CDCl3) δ = 8.34 – 
8.29 (m, 2H), 8.24 – 8.20 (m, 2H), 6.74 (ddd, J = 10.2, 2.9, 1.5 Hz, 
1H), 6.09 (dt, J = 5.1, 2.6 Hz, 1H), 6.06 (dd, J = 10.2, 2.1 Hz, 1H), 2.59 
– 2.52 (m, 2H), 2.37 (ddd, J = 17.5, 10.5, 5.2 Hz, 1H), 2.17 (s, 3H), 
2.02 (ddd, J = 14.4, 10.5, 5.3 Hz, 1H), 1.93 (ddd, J = 14.4, 10.6, 5.2 
Hz, 1H), 1.16 (s, 3H), 1.03 (d, J = 6.9 Hz, 3H). 13C NMR (126 MHz, 
CDCl3) δ = 207.7, 202.3, 164.0, 150.9, 142.6, 135.0, 130.9, 130.0, 
123.9, 71.7, 49.2, 40.8, 38.4, 30.2, 29.6, 19.9, 10.1. HRMS (ESI) Exact 
mass calculated for C19H21NO6Na+ [M+Na]+: 382.12611, found: 
382.12626. 
(1R,2S,8aR)-1,8a-dimethyl-6-oxo-1,2,6,7,8,8a-hexahydro-
naphthalen-2-yl 4-nitrobenzoate (16): A mixture of ester 15 
(14.1 mg, 39 µmol, 1.0 eq.), pyrrolidine (6 μL, 78 µmol, 2.0 eq.) and 
acetic acid (4.5 μL, 78 µmol, 2.0 eq.) in CH2Cl2 (0.4 mL) was stirred 
for 3 h 10 min at rt, before additional pyrrolidine (2.0 eq.) and acetic 
acid (2.0 eq.) were added. After in total 9 h at rt the mixture was 
quenched by addition of 0.1 M HCl and diluted with CH2Cl2. The layers 
were separated and the aqueous layer was extracted with CH2Cl2 
(3 x). The combined organic layers were dried over Na2SO4, filtered 
and concentrated. Since the residue still contained enone 15 
(monitored by 1H NMR), a mixture of crude material, pyrrolidine 
(2.0 eq.) and acetic acid (2.0 eq.) in CH2Cl2 (0.5 mL) was stirred for 
additional 14 h. The same work-up procedure was carried out as 
described before and the obtained residue was subjected to flash 
column chromatography (pentane/Et2O 1:1) to give the dienone 16 
(8.1 mg, 39.2 µmol, 61 %) as a colorless solid. 
M.p. = 162.3 – 163.6°C. TLC: Rf = 0.54 (SiO2, pentane/Et2O 1:2). [𝛼]$%- 
= +699° (c = 0.41, CHCl3). FTIR (neat): ν, = 3111, 2971, 2944, 1721, 
1663, 1527, 1268, 1093, 719 cm−1. 1H NMR (500 MHz, CDCl3) δ = 
8.31 (d, J = 8.7 Hz, 2H), 8.18 (d, J = 8.6 Hz, 2H), 6.41 (d, J = 9.7 Hz, 
1H), 6.33 (dd, J = 9.7, 5.2 Hz, 1H), 5.85 (s, 1H), 5.64 (t, J = 4.9 Hz, 
1H), 2.61 (ddd, J = 18.0, 14.2, 5.4 Hz, 1H), 2.52 (ddd, J = 18.0, 5.3, 
2.1 Hz, 1H), 2.14 (ddd, J = 13.4, 5.4, 2.2 Hz, 1H), 2.08 (dd, J = 7.2, 
4.7 Hz, 1H), 1.81 (td, J = 13.8, 5.2 Hz, 1H), 1.41 (s, 3H), 1.12 (d, J = 
7.1 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ = 199.2, 164.5, 160.7, 
150.8, 135.5, 132.4, 131.4, 130.8, 126.6, 123.9, 71.5, 41.1, 35.8, 34.3, 
34.1, 18.4, 10.5. HRMS (ESI) Exact mass calculated for C19H20NO5+ 
[M+H]+: 342.13360, found: 342.13368. 
(1aS,2R,3R,3aR,7bR)-3,3a-dimethyl-6-oxo-1a,2,3,3a,4,5,6,7b-
octahydronaphtho[1,2-b]oxiren-2-yl acetate (17): A mixture of a,b-
epoxy ketone 20 (19.3 mg, 72 µmol, 1.0 eq), pyrrolidine (12 μL, 
0.14 mmol, 2.0 eq.) and acetic acid (8.2 μL, 0.14 mmol, 2.0 eq) in 
CH2Cl2 (0.6 mL) was stirred at rt overnight. The mixture was quenched 
by addition of 0.1 M HCl and diluted with CH2Cl2. The layers were 
separated and the aqueous layer was extracted with CH2Cl2 (3 x). The 
combined organic layers were dried over Na2SO4, filtered and 
concentrated. The crude residue was subjected to flash column 
chromatography (pentane/Et2O 1:1) to yield epoxy octalone 17 
(14.2 mg, 57 µmol, 79 %) as a colorless solid. 
M.p. = 81.8 – 85.8°C. TLC: Rf = 0.44 (SiO2, pentane/Et2O 1:1).	[𝑎]$%0 = 
+212.6° (c = 0.62, CHCl3). FTIR (neat): ν, = 2923, 2853, 1744, 1681, 
1374, 1230, 1026 cm−1. 1H NMR (500 MHz, CDCl3) δ = 6.17 (s, 1H), 
5.42 – 5.39 (m, 1H), 3.56 (d, J = 3.3 Hz, 1H), 3.50 (dd, J = 3.3, 2.1 Hz, 
1H), 2.60 (ddd, J = 18.3, 14.1, 5.6 Hz, 1H), 2.52 – 2.42 (m, 1H), 2.15 
(s, 3H), 1.99 (ddd, J = 13.3, 5.4, 2.2 Hz, 1H), 1.87 (qd, J = 7.3, 3.9 Hz, 
1H), 1.71 (td, J = 13.7, 5.4 Hz, 1H), 1.21 (s, 3H), 0.94 (d, J = 7.2 Hz, 
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3H). 13C NMR (126 MHz, CDCl3) δ = 198.1, 170.4, 160.6, 131.7, 70.8, 
53.0, 53.0, 35.6, 34.7, 34.1, 34.0, 21.1, 18.8, 9.8. HRMS (ESI) Exact 
mass calculated for C14H19O4+ [M+H]+: 251.12779, found: 251.12786. 
(1S,2R,3R,4R,6S)-3,4-dimethyl-5-oxo-4-(3-oxobutyl)-7-oxabi-
cyclo[4.1.0]heptan-2-yl 4-nitrobenzoate (13) and 
(1S,3R,4R,5R,6S)-5-hydroxy-3,4-dimethyl-3-(3-oxobutyl)-7-oxabi-
cyclo[4.1.0]heptan-2-one (19): Ester 15 (25.6 mg, 71 µmol, 1.0 eq.) 
was dissolved in THF (1.5 mL) and cooled to 0°C. Hydrogen peroxide 
(30 % in H2O, 675 µL, 7.12 mmol, 100 eq.) and Triton B (40 % in 
MeOH, 32 µL, 71 µmol, 1.0 eq.) were added and the reaction mixture 
was stirred for 2 h 40 min at 0°C, before it was quenched by addition 
of sat. aq. Na2CO3 and diluted with Et2O. The layers were separated 
and the aqueous layer was extracted with Et2O (3 x). The combined 
organic layers were dried over Na2SO4, filtered and the solvent was 
removed under reduced pressure. The crude residue was subjected 
to flash column chromatography (Et2O/pentane 2:1) to give the epoxy 
ester 13 (5.80 mg, 15 µmol, 22 %) as a colorless solid and epoxy 
alcohol 19 (9.0 mg, 40 µmol, 56 %) as a colorless oil.  
Epoxy ester 13: M.p. = 112.2 – 113.9°C. TLC: Rf = 0.43 (SiO2, 
pentane/Et2O 1:1). [𝛼]$%1 = +27.9° (c = 0.29, CHCl3). FTIR (neat): ν, = 
2919, 1714, 1528, 1348, 1266, 1099, 718 cm−1. 1H NMR (500 MHz, 
CDCl3) δ = 8.31 (d, J = 8.8 Hz, 2H), 8.15 – 8.12 (m, 2H), 5.74 (t, J = 
3.0 Hz, 1H), 3.85 (t, J = 3.6 Hz, 1H), 3.45 (d, J = 4.0 Hz, 1H), 2.56 (qd, 
J = 7.3, 2.9 Hz, 1H), 2.48 – 2.32 (m, 2H), 2.15 (s, 3H), 1.95 (ddd, J = 
15.4, 9.9, 5.6 Hz, 1H), 1.86 (ddd, J = 14.7, 9.9, 5.8 Hz, 1H), 1.19 (s, 
3H), 1.04 (d, J = 7.3 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ = 208.8, 
207.7, 164.5, 151.0, 134.6, 131.0, 124.0, 74.2, 55.1, 54.4, 48.1, 38.4, 
33.5, 31.8, 30.3, 21.2, 11.8. HRMS (ESI) Exact mass calculated for 
C19H21O7NNa+ [M+Na]+: 398.12102, found: 398.12103. 
Epoxy alcohol 19: TLC: Rf = 0.27 (SiO2, pentane/Et2O 1:1). [𝛼]$%* = –
65.5° (c = 0.20, CHCl3). FTIR (neat): ν,  = 3481, 2917, 2849, 1700, 
1369, 1259, 1167 cm−1. 1H NMR (500 MHz, CDCl3) δ = 4.34 (d, J = 3.9 
Hz, 1H), 3.64 (t, J = 3.6 Hz, 1H), 3.36 (d, J = 3.9 Hz, 1H), 2.38 (ddd, J 
= 16.4, 10.5, 5.4 Hz, 1H), 2.33 – 2.25 (m, 1H), 2.17 (qd, J = 7.4, 2.7 
Hz, 1H), 2.12 (s, 3H), 2.04 (d, J = 4.6 Hz, 1H), 1.85 (ddd, J = 13.9, 
10.5, 5.3 Hz, 1H), 1.74 (ddd, J = 14.0, 10.4, 5.4 Hz, 1H), 1.09 (s, 3H), 
1.03 (dd, J = 7.3, 1.1 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ = 209.9, 
208.4, 70.6, 57.0, 54.9, 48.0, 38.7, 33.8, 31.7, 30.2, 21.8, 11.5. HRMS 
(ESI) Exact mass calculated for C12H19O4+ [M+H]+: 227.12779, found: 
227.12784. 
(1S,2R,3R,4R,6S)-3,4-dimethyl-5-oxo-4-(3-oxobutyl)-7-oxabi-
cyclo[4.1.0]heptan-2-yl acetate (20): To a solution of epoxy alcohol 
19 (102 mg, 0.45 mmol, 1.0 eq.) in CH2Cl2 (4.0 mL) was added Et3N 
(127 µL, 0.90 mmol, 2.0 eq.), Ac2O (169 µL, 1.8 mmol, 4.0 eq.) and 
DMAP (5.5 mg, 0.045 mmol, 0.1 eq.). The resulting mixture was 
stirred at rt for 1 h, then quenched by addition of 0.1 M HCl and diluted 
with CH2Cl2. After the layers were separated, the aqueous layer was 
extracted with CH2Cl2 (3 x). The combined organic layers were dried 
over Na2SO4, filtered and the solvent was removed under reduced 
pressure. The crude material was subjected to flash column 
chromatography (pentane/Et2O 1:1) to afford acetate 20 (107 mg, 
0.45 mmol, 88 %) as a colorless solid.  
M.p. = 71.8 – 73.9°C. TLC: Rf = 0.45 (SiO2, pentane/Et2O 1:1). [𝛼]$%* = 
–14.5° (c = 0.23, CHCl3). FTIR (neat): ν, = 2918, 2849, 1745, 1700, 
1462, 1369, 1227, 1016, 977 cm−1. 1H NMR (400 MHz, CDCl3) δ = 
5.43 (t, J = 3.1 Hz, 1H), 3.72 – 3.68 (m, 1H), 3.36 (d, J = 3.9 Hz, 1H), 
2.46 – 2.26 (m, 3H), 2.13 (s, 3H), 2.10 (s, 3H), 1.88 (ddd, J = 14.3, 
10.1, 5.5 Hz, 1H), 1.77 (ddd, J = 14.3, 10.2, 5.7 Hz, 1H), 1.08 (s, 3H), 
0.95 (d, J = 7.3 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ = (126 MHz, 
CDCl3) δ = 209.3, 207.9, 170.6, 72.3, 55.0, 54.5, 48.1, 38.5, 32.7, 31.8, 
30.2, 21.2, 20.9, 11.5. HRMS (ESI) Exact mass calculated for 
C14H20O5Na+ [M+Na]+: 291.12029, found: 291.12025. 
(1R,2R,3R,5S,6S)-5,6-dihydroxy-2,3-dimethyl-4-oxo-3-(3-oxo-
butyl)cyclohexyl acetate (21): A solution of epoxy ketone 20 
(108 mg, 0.40 mmol, 1.0 eq.) in toluene (4.5 mL) was cooled to 0°C 
and BF3·Et2O (56.2 µL, 0.44 mmol, 1.1 eq.) was added. The resulting 
yellow solution was stirred for 7 h and then quenched by addition of 
sat. aq. NaHCO3. The mixture was extracted with EtOAc (3 x) and the 
combined organic layers were dried over Na2SO4, filtered and 
concentrated. The crude material was subjected to flash column 
chromatography (EtOAc) to give the 1,2-diol 21 (50.4 mg, 0.40 mmol, 
44 %) as a colorless oil. 
TLC: Rf = 0.25 (SiO2, EtOAc). [𝛼]$%1 = –1.5° (c = 0.21, CHCl3). FTIR 
(neat): ν, = 3453, 2918, 2848, 1743, 1713, 1375, 1238, 1103, 1005 
cm−1. 1H NMR (500 MHz, CDCl3) δ = 5.50 (t, J = 3.3 Hz, 1H), 4.60 (d, 
J = 10.8 Hz, 1H), 3.59 (dd, J = 10.8, 3.4 Hz, 1H), 3.52 (brs, 1H), 2.58 
(brs, 1H), 2.47 – 2.28 (m, 2H), 2.19 (s, 3H), 2.16 (s, 3H), 2.01 (ddd, J 
= 15.2, 10.3, 5.3 Hz, 1H), 1.88 (qd, J = 7.0, 3.1 Hz, 1H), 1.65 (ddd, J 
= 14.5, 10.4, 5.3 Hz, 1H), 1.26 (s, 3H), 1.04 (d, J = 7.0 Hz, 3H). 13C 
NMR (126 MHz, CDCl3) δ = 211.9, 208.1, 170.8, 75.5, 73.9, 73.9, 49.5, 
38.9, 36.2, 30.2, 29.2, 21.3, 21.1, 10.9. HRMS (ESI) Exact mass 
calculated for C14H22O6Na+ [M+Na]+: 309.13086, found: 309.13086. 
(1S,2R,3R,4R,5R)-4,5-dimethyl-6-oxo-5-(3-oxobutyl)cyclohexane-
1,2,3-triyl triacetate (22): To a solution of 1,2-diol 21 (3.9 mg, 
14 µmol, 1.0 eq.) in CH2Cl2 (0.3 mL) was added Et3N (6 µL, 41 µmol, 
3.0 eq.), Ac2O (9 µL, 95 µmol, 7.0 eq.) and DMAP (0.3 mg, 2.7 µmol, 
0.2 eq.) at rt. The resulting mixture was stirred at rt for 1 h, then 
quenched by addition of a 0.1 M HCl solution and diluted with CH2Cl2. 
The layers were separated and the aqueous layer was extracted with 
CH2Cl2 (3 x). The combined organic layers were dried over Na2SO4, 
filtered and the solvent was removed under reduced pressure. The 
crude material was subjected to flash column chromatography 
(pentane/Et2O 1:2) to afford the tri-acetylated compound 22 (2.2 mg, 
6.0 µmol, 44 %) as a colorless oil. 
TLC: Rf = 0.39 (SiO2, pentane/Et2O 1:2). 1H NMR (400 MHz, CDCl3) δ 
= 5.72 (d, J = 12.0 Hz, 1H), 5.55 (t, J = 3.2 Hz, 1H), 5.08 (dd, J = 12.0, 
3.4 Hz, 1H), 2.42 (ddd, J = 16.3, 10.7, 5.1 Hz, 1H), 2.36 – 2.26 (m, 
1H), 2.19 (s, 3H), 2.17 (s, 3H), 2.15 (s, 3H), 2.02 (s, 3H), 2.00 – 1.91 
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(m, 2H), 1.62 (ddd, J = 14.5, 10.6, 5.2 Hz, 1H), 1.30 (s, 3H), 1.03 (d, J 
= 7.0 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ = 208.0, 204.3, 170.3, 
170.2, 169.8, 72.9, 72.5, 71.2, 50.6, 38.8, 35.3, 30.1, 29.3, 21.0, 21.0, 
20.8, 20.7, 10.8. HRMS (ESI) Exact mass calculated for C18H26O8Na+ 
[M+Na]+: 393.15199, found: 393.15203. 
(1R,2S,4R,5R,6R)-6-acetoxy-4,5-dimethyl-3-oxo-4-(3-oxobutyl)-
cyclohexane-1,2-diyl dibenzoate (24): To a solution of 1,2-diol 21 
(3.7 mg, 13 µmol, 1.0 eq.) in CH2Cl2 (0.3 mL) was added Et3N (3.7 µL, 
26 µmol, 2.0 eq.), BzCl (6.0 µL, 52 µmol, 4.0 eq.) and DMAP 
(0.15 mg, 1.3 µmol, 0.1 eq.) at 0°C. The reaction mixture was allowed 
to warm up to rt and stirred for 2 h 15 min, before additional BzCl 
(20 µL, 0.17 mmol, 13 eq.) was added. After stirring for 19 h at rt, 
additional Et3N (7 µL, 52 µmol, 4.0 eq.) was added to the mixture and 
the solvent was evaporated after the mixture was stirred for in total 
23 h 15 min. The residue was subjected to flash column 
chromatography (SiO2, pentane/Et2O 1:1) to afford the dibenzylated 
product 24 (1.4 mg, 3 µmol, 22 %) as a colorless solid. 
M.p. = 131.3 – 134.4°C. TLC: Rf = 0.34 (SiO2, pentane/Et2O, 1:1). [𝛼]$%1 = –39.0° (c = 1.10, CHCl3). FTIR (neat): ν, = 2926, 1720, 1452, 
1267, 1224, 1094, 710 cm−1. 1H NMR (500 MHz, Chloroform-d) δ = 
8.04 – 7.99 (m, 2H), 7.93 – 7.88 (m, 2H), 7.56 – 7.51 (m, 2H), 7.43 – 
7.36 (m, 4H), 6.17 (d, J=11.9, 1H), 5.78 (t, J=3.3, 1H), 5.56 (dd, 
J=11.9, 3.5, 1H), 2.49 (ddd, J=16.1, 10.8, 4.9, 1H), 2.38 (ddd, J=16.8, 
10.6, 5.0, 1H), 2.22 (s, 3H), 2.15 (s, 3H), 2.10 (qd, J=7.2, 3.3, 1H), 
2.04 (td, J=10.3, 5.3, 1H), 1.68 (ddd, J=14.4, 10.7, 5.0, 1H), 1.42 (s, 
3H), 1.10 (d, J=6.9, 3H). 13C NMR (126 MHz, CDCl3) δ = 208.2, 204.1, 
170.0, 165.9, 165.4, 133.6 (2C), 130.0 (2C), 129.8 (2C), 129.2, 129.1, 
128.6 (2C), 128.6 (2C), 73.7, 72.6, 71.8, 50.7, 38.9, 35.7, 30.2, 29.4, 
21.0 (2C), 10.9. HRMS (ESI) Exact mass calculated for C28H30O8Na+ 
[M+H]+: 517.18328, found: 517.18333. 
(1R,2R,3R,5S,6R)-5-((tert-butyldimethylsilyl)oxy)-6-hydroxy-2,3-
dimethyl-4-oxo-3-(3-oxobutyl)cyclohexyl acetate (29) and 
(1R,2R,3R,5S,6S)-6-((tert-butyldimethylsilyl)oxy)-5-hydroxy-2,3-
dimethyl-4-oxo-3-(3-oxobutyl)cyclohexyl acetate (30): To a 
solution of 1,2-diol 21 (22.3 mg, 78 µmol, 1.0 eq), imidazole 
(13.3 mg, 0.20 mmol, 2.5 eq) and DMAP (4.8 mg, 39 µmol 0.5 eq.) in 
CH2Cl2 (0.9 mL) was added TBSCl (47.5 mg, 0.31 µmol, 4.0 eq) and 
the mixture was stirred at rt for 15 h. The reaction mixture was 
quenched by addition of sat. aq. NH4Cl solution, and extracted with 
CH2Cl2 (3 x). The combined organic layers were washed with H2O and 
brine, dried over Na2SO4 and concentrated. The crude material was 
subjected to flash column chromatography (pentane/Et2O, 1:2) to 
afford the silyl ether 29 (20.8 mg, 51.9 µmol, 67 %) as a colorless oil 
and impure 30. After a second flash column chromatography 
(pentane/Et2O 4:1 to 2:1 to 1:1) silyl ether 30 (7.5 mg, 18.7 µmol, 
24 %) was obtained as a colorless solid. 
TBS ether 29: TLC: Rf = 0.21 (SiO2, pentane/Et2O 1:2). [𝛼]$%0 = –31.7° 
(c = 0.99, CHCl3). FTIR (neat): ν,  = 3483, 2930, 2857, 1747, 1711, 
1234, 1126, 1007, 839, 781 cm−1. 1H NMR (500 MHz, CDCl3) δ = 5.55 
(t, J=3.3, 1H), 4.66 (d, J=10.7, 1H), 3.67 (ddd, J=10.7, 3.3, 1.3, 1H), 
2.46 (ddd, J=17.0, 11.0, 4.7, 1H), 2.39 (s, 1H), 2.26 (ddd, J=16.9, 11.0, 
5.0, 1H), 2.17 (s, 3H), 2.14 (s, 3H), 1.95 (ddd, J=14.4, 11.0, 4.7, 1H), 
1.85 (qd, J=7.0, 3.2, 1H), 1.57 (ddd, J=14.4, 11.0, 5.0, 1H), 1.21 (s, 
3H), 1.00 (d, J=7.1, 3H), 0.93 (s, 9H), 0.18 (s, 3H), 0.03 (s, 3H). 13C 
NMR (126 MHz, CDCl3) δ = 210.0, 208.4, 170.6, 75.9, 74.2, 73.9, 50.5, 
38.9, 35.5, 30.1, 29.3, 26.0, 21.8, 21.1, 18.8, 10.8, -4.3, -5.5. HRMS 
(ESI) Exact mass calculated for C20H37O6Si+ [M+H]+: 401.23539, 
found: 401.23538 and for C20H36O6SiNa+ [M+Na]+: 423.21734, found: 
423.21699. 
TBS ether 30: M.p. = 97.1 – 99.3°C. TLC: Rf = 0.65 (SiO2, 
pentane/Et2O 1:2). [𝛼]$%1 = –7.1° (c = 0.31, CHCl3). FTIR (neat): ν,  = 
3492, 2930, 2857, 1746, 1720, 1372, 1237, 1165, 1010, 838, 781 
cm−1. 1H NMR (500 MHz, CDCl3) δ = 5.37 (t, J=3.3, 1H), 4.56 (dd, 
J=10.4, 3.9, 1H), 3.50 (dd, J=10.4, 3.6, 1H), 3.43 (d, J=4.0, 1H), 2.42 
(ddd, J=16.1, 10.7, 5.1, 1H), 2.34 (ddd, J=16.9, 10.6, 5.2, 1H), 2.16 (s, 
3H), 2.14 (s, 3H), 1.99 (ddd, J=14.4, 10.5, 5.0, 1H), 1.81 (qd, J=7.0, 
3.1, 1H), 1.63 (ddd, J=14.4, 10.7, 5.2, 1H), 1.23 (s, 3H), 1.01 (d, J=7.0, 
3H), 0.87 (s, 9H), 0.12 (s, 3H), 0.07 (s, 3H). 13C NMR (126 MHz, 
CDCl3) δ = 212.8, 208.2, 170.3, 76.3, 75.2, 74.5, 49.3, 38.9, 35.8, 30.2, 
29.3, 25.7, 21.1 (2C), 18.3, 10.8, -4.5, -5.0. HRMS (ESI) Exact mass 
calculated for C20H36O6SiNa+ [M+Na]+: 423.21734, found: 423.21744. 
(5aR,6R,7R,8R,9aS)-2,2,4,4-tetraisopropyl-7,8-dimethyl-9-oxo-8-
(3-oxobutyl)hexahydrobenzo[f][1,3,5,2,4]trioxadisilepin-6-yl 
acetate (31): 1,2-Diol 21 (50.4 mg, 0.18 mmol, 1.0 eq.) was dissolved 
in CH2Cl2 (1.0 mL), before imidazole (48.0 mg, 0.70 mmol, 4.0 eq.) 
and TIPDSCl2 (67 µL, 0.21 mmol, 1.2 eq.) were added. The turbid 
mixture was stirred for 9 h 15 min, before it was diluted by addition of 
sat. aq. NH4Cl solution and CH2Cl2. The layers were separated and 
the aqueous layer was extracted with CH2Cl2 (2 x). The combined 
organic layers were washed with H2O and brine, dried over Na2SO4, 
filtered and concentrated. The residue was subjected to flash column 
chromatography (pentane/Et2O 2:1) to afford fully protected triol 31 
(64.1 mg, 0.12 mmol, 69 %) as a colorless oil. 
TLC: Rf = 0.67 (SiO2, pentane/Et2O 1:1). [𝛼]$%%  = +10.2° (c = 0.57, 
CHCl3). FTIR (neat): ν, = 3514, 2945, 2867, 1755, 1727, 1464, 1367, 
1234, 1165, 1054, 985 cm−1. 1H NMR (500 MHz, CDCl3) δ = 5.50 (t, J 
= 3.5 Hz, 1H), 4.79 (d, J = 10.1 Hz, 1H), 3.82 (dd, J = 10.2, 3.7 Hz, 
1H), 2.47 (ddd, J = 16.1, 11.1, 4.6 Hz, 1H), 2.31 (ddd, J = 16.6, 11.1, 
4.9 Hz, 1H), 2.14 (s, 3H), 2.13 (s, 3H), 1.97 (ddd, J = 15.3, 11.1, 4.5 
Hz, 1H), 1.83 (qd, J = 7.0, 3.0 Hz, 1H), 1.56 (ddd, J = 14.4, 11.1, 4.9 
Hz, 1H), 1.21 (s, 3H), 1.11-0.96 (m, 31H). 13C NMR (126 MHz, CDCl3) 
δ = 208.6, 208.4, 170.2, 76.7, 76.6, 74.8, 50.0, 39.0, 35.3, 30.1, 29.6, 
21.4, 21.1, 17.6 – 17.1 (8C), 13.0, 12.9, 12.8, 12.1, 10.9. HRMS (ESI) 
Exact mass calculated for C26H49O7Si2+ [M+H]+: 529.30113, found: 
529.30172 and for C26H48O7Si2Na+ [M+Na]+: 551.28308, found: 
551.28343. 
(5aR,6R,7R,7aR,11bR)-2,2,4,4-tetraisopropyl-7,7a-dimethyl-10-
oxo-5a,6,7,7a,8,9,10,11b-octahydronaphtho[1,2-f][1,3,5,2,4]tri-
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oxadisilepin-6-yl acetate (32): A mixture of fully protected triol 31 
(64 mg, 0.12 mmol, 1.0 eq.), pyrrolidine (20 μL, 0.24 mmol, 2.0 eq.) 
and acetic acid (14 μL, 0.24 mmol, 2.0 eq.) in toluene (3.5 mL) was 
stirred at rt for 18 h. The reaction mixture was quenched by addition 
of a 0.1 M HCl solution. The layers were separated and the aqueous 
layer was extracted with CH2Cl2 (3 x). The combined organic layers 
were dried over Na2SO4, filtered and concentrated. The residue was 
subjected to flash column chromatography (pentane/Et2O 2:1) to 
afford the octalone 32 (42 mg, 82 µmol, 68 %) as a colorless solid.  
M.p. = 132.3 – 134.5°C. TLC: Rf = 0.41 (SiO2, pentane/Et2O 2:1). [𝛼]$%* = +31.7° (c = 0.31, CHCl3). FTIR (neat): ν, = 2946, 2925, 1751, 
1681, 1469, 1228, 1147, 980 cm−1. 1H NMR (400 MHz, CDCl3) δ = 6.37 
(dd, J = 2.1, 0.9 Hz, 1H), 5.40 (t, J = 3.3 Hz, 1H), 4.63 (dd, J = 9.6, 2.0 
Hz, 1H), 3.75 (dd, J = 9.6, 3.7 Hz, 1H), 2.48 (ddd, J = 17.0, 14.6, 5.0 
Hz, 1H), 2.35 (dddd, J = 17.0, 4.4, 3.1, 1.0 Hz, 1H), 2.11 (s, 3H), 2.06 
(ddd, J = 13.4, 5.1, 3.1 Hz, 1H), 1.78 – 1.62 (m, 2H), 1.29 (s, 3H), 1.11 
– 0.96 (m, 31H). 13C NMR (126 MHz, CDCl3) δ = 199.4, 170.3, 166.9, 
123.0, 77.3, 75.2, 72.3, 42.8, 38.7, 37.0, 33.4, 21.2, 19.1, 17.6 – 17.2 
(8C), 13.0, 12.9, 12.4, 12.0, 11.0. HRMS (ESI) Exact mass calculated 
for C26H47O6Si2+ [M+H]+: 511.29057, found: 511.29098 and for 
C26H46O6Si2Na+ [M+Na]+: 533.27251, found: 533.27276. 
(5aR,6R,7R,7aR,9S,11bR)-9-(2-hydroxypropan-2-yl)-2,2,4,4-
tetraisopropyl-7,7a-dimethyl-10-oxo-5a,6,7,7a,8,9,10,11b-octa-
hydronaphtho[1,2-f][1,3,5,2,4]trioxadisilepin-6-yl acetate (33): To 
a solution of octalone 32 (5.5 mg, 10.8 µmol, 1.0 eq.) in THF (0.3 mL) 
at –78°C was added a solution of LHMDS (1M in THF, 54 µL, 54 µmol, 
5.0 eq.). After 1 h a solution of ZnCl2 (1M in THF, 22 µL, 22 µmol, 
2.0 eq.) was added and the reaction mixture was allowed to warm up 
to –40°C and stirred for 15 min at this temperature. Freshly distilled 
acetone (8 µL, 0.11 mmol, 10 eq.) was added and after stirring for 
25 min, the reaction mixture was quenched by addition of an aq. 
tartaric acid solution (5 %). The mixture was extracted with Et2O (3 x) 
and the combined organic layers were washed with brine, dried over 
Na2SO4, filtered and concentrated. The residue was subjected to flash 
column chromatography (pentane/Et2O 2:1) to give the tertiary alcohol 
33 (4.1 mg, 7.2 µmol, 67 %) as a colorless oil. 
TLC: Rf = 0.41 (SiO2, pentane/Et2O 3:1). [𝛼]$%%  = +40.5° (c = 0.21, 
CHCl3). FTIR (neat): ν, = 2945, 2868, 1751, 1653, 1464, 1377, 1226, 
1125, 887 cm−1. 1H NMR (500 MHz, CDCl3) δ = 6.33 (d, J = 2.0 Hz, 
1H), 5.41 (t, J = 3.3 Hz, 1H), 4.97 (brs, 1H), 4.62 (dd, J = 9.7, 2.0 Hz, 
1H), 3.77 – 3.66 (m, 1H), 2.55 (dd, J = 14.6, 4.3 Hz, 1H), 2.12 (s, 3H), 
2.03 (dd, J = 12.9, 4.4 Hz, 1H), 1.66 (dq, J = 7.1, 4.1 Hz, 1H), 1.48 (t, 
J = 13.8, 1H), 1.32 (s, 3H), 1.22 (s, 3H), 1.21 (s, 3H), 1.11 – 0.96 (m, 
31H). 13C NMR (126 MHz, CDCl3) δ = 203.2, 170.2, 167.6, 123.6, 77.0, 
75.1, 72.5, 72.2, 50.7, 43.1, 40.0, 39.4, 28.4, 24.9, 21.2, 19.0, 17.6 – 
17.2 (8C), 13.0, 12.9, 12.4, 12.0, 11.0. HRMS (ESI) Exact mass 
calculated for C29H53O7Si2+ [M+H]+: 569.33243, found: 569.33286. 
Exact mass calculated for C29H52O7Si2Na+ [M+Na]+: 591.31428, found: 
591.31437. 
(5aR,6R,7R,7aR,9S,11bR)-2,2,4,4-tetraisopropyl-7,7a-dimethyl-
10-oxo-9-(prop-1-en-2-yl)-5a,6,7,7a,8,9,10,11b-octahydro-
naphtho[1,2-f][1,3,5,2,4]trioxadisilepin-6-yl acetate (34): Tertiary 
alcohol 33 (18.7 mg, 33 µmol, 1.0 eq.) was dissolved in toluene 
(0.7 mL) and Burgess reagent (49 mg, 0.20 mmol, 6.1 eq.) was 
added. The reaction mixture was stirred at rt for 26 h, before it was 
diluted with H2O and extracted with Et2O (3 x). The combined organic 
layers were dried over Na2SO4, filtered and concentrated. The residue 
was subjected to flash column chromatography (pentane/Et2O 7:1) to 
afford the isopropenylated compound 34 (9.7 mg, 17.6 µmol, 54 %) as 
a colorless solid.  
M.p. = 108.5 – 112.2°C. TLC: Rf = 0.76 (SiO2, pentane/Et2O 3:1). [𝛼]$%* = +86.2° (c = 0.49, CHCl3). FTIR (neat): ν, = 2945, 2868, 1751, 
1679, 1464, 1229, 1150, 980, 887 cm−1. 1H NMR (500 MHz, CDCl3) δ 
= 6.36 (d, J = 2.0 Hz, 1H), 5.41 (t, J = 3.3 Hz, 1H), 4.99 (t, J = 1.6 Hz, 
1H), 4.82 (d, J = 1.7 Hz, 1H), 4.63 (dd, J = 9.6, 2.0 Hz, 1H), 3.76 (dd, 
J = 9.6, 3.8 Hz, 1H), 3.17 (dd, J = 14.4, 4.5 Hz, 1H), 2.12 (s, 3H), 2.00 
(dd, J = 13.0, 4.6 Hz, 1H), 1.86 (t, J = 13.7 Hz, 1H), 1.74 (s, 3H), 1.69 
(qd, J = 7.0, 3.0 Hz, 1H), 1.35 (s, 3H), 1.12 – 0.95 (m, 31H). 13C NMR 
(126 MHz, CDCl3) δ = 198.7, 170.2, 165.8, 143.4, 123.1, 114.5, 77.1, 
75.3, 72.2, 50.2, 43.2, 42.9, 39.3, 21.2, 20.3, 19.1, 17.6 – 17.2 (8C), 
13.0, 12.9, 12.3, 12.0, 11.0. HRMS (ESI) Exact mass calculated for 
C29H51O6Si2+ [M+H]+: 551.32187, found: 551.32224. 
Guignarderemophilane C (1): The fully protected triol 34 (10 mg, 
18 µmol, 1.0 eq.) was dissolved in THF (0.35 mL) and cooled to 0°C. 
A solution of TBAF (1 M in THF, 73 µL, 73 µmol, 4.0 eq.) was added 
and the reaction mixture was stirred at 0°C for 50 min, before it was 
treated with sat. aq. NH4Cl solution. The layers were separated and 
the aqueous layer was extracted with EtOAc (3 x). The combined 
organic layers were dried over Na2SO4, filtered and concentrated. The 
crude material was dissolved in a solution of NH3 (7 M in MeOH, 
0.35 mL) and stirred at rt for 2 h. The solvent was evaporated (at 30°C 
bath temperature) and the residue was purified by flash column 
chromatography (CH2Cl2/MeOH 12:1) to afford a 4.6:1 mixture of 
guignarderemophilane C (1) and D (2) (3.5 mg, 13.1 µmol, 72 % over 
two steps). For analytical purposes, the mixture of 1 and 2 was purified 
by semi-preparative HPLC using the conditions given below. The 
residue was dissolved in a mixture of H2O/MeCN/MeOH (10:4:1, 
0.8 mL) and in total eight runs had to be carried out with injection of 
100 µL of the sample per run. Two fractions were collected from 18.00 
to 19.20 min (fraction 1), and from 19.20 to 21.00 min (fraction 2), 
respectively. The first fraction gave pure guignarderemophilane C (1) 
(2.2 mg, 63 %) and the second fraction gave a 1:1 mixture of 
guignarderemophilanes C (1) and D (2) (1.1 mg, 31 %) after 
concentration by rotary evaporator and lyophilizer. 
Column: Synergi Hydro-RP 10 μm 80 Å, 150 mm x 10.0 mm; solvent 
A: H2O; solvent B: MeCN; flow = 4.6 mL/min; T = rt; UV detection at 
222 nm; solvent system: isocratic, [B] = 18 %.  
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TLC: Rf = 0.43 (SiO2, CH2Cl2/MeOH 12:1) [𝛼]$%&  = +35.0° (c = 0.88, 
MeOH). FTIR (neat): ν, = 3401, 2968, 2940, 2881, 1662, 1443, 1327, 
1132, 1101, 1079, 889 cm−1. 1H NMR (500 MHz, MeOD) δ = 6.20 (d, 
J = 2.0 Hz, 1H), 4.93 (t, J = 1.7 Hz, 1H), 4.82 – 4.80 (m, 1H), 4.48 (dd, 
J = 10.4, 2.0 Hz, 1H), 3.86 (t, J = 3.0 Hz, 1H), 3.38 (dd, J = 10.4, 3.3 
Hz, 1H), 3.24 (dd, J = 14.4, 4.6 Hz, 1H), 1.99 (dd, J = 13.0, 4.6 Hz, 
1H), 1.88 (t, J = 13.7 Hz, 1H), 1.70 (t, J = 1.0 Hz, 3H), 1.51 (qd, J = 
7.1, 2.8 Hz, 1H), 1.41 (s, 3H), 1.14 (d, J = 7.1 Hz, 3H). 13C NMR (126 
MHz, MeOD) δ = 201.7, 172.6, 144.9, 122.0, 114.7, 77.4, 75.6, 70.1, 
51.3, 45.9, 44.4, 40.8, 20.2, 19.8, 11.8. HRMS (ESI) Exact mass 
calculated for C15H22O4Na+ [M+Na]+: 289.14103, found: 289.14085. 
Guignarderemophilane D (2): A solution of guignarderemophilane C 
(1) (2.0 mg, 7.5 µmol, 70 %) in NaOMe (0.5 M in MeOH, 1.0 mL) was 
stirred for 6 h at 0°C. The reaction was quenched by addition of sat. 
aq. NH4Cl solution and the resulting turbid mixture was extracted with 
EtOAc (3 x). The combined organic layers were dried over Na2SO4, 
filtered and concentrated. The crude residue was subjected to flash 
column chromatography (CH2Cl2/MeOH 14:1) to give guignard-
eremophilane D (2) (1.4 mg, 5.3 µmol, 70 %) as a colorless solid. 
TLC: Rf = 0.23 (SiO2, CH2Cl2/MeOH 14:1) [𝛼]$%*  = +38.2° (c = 0.70, 
MeOH). FTIR (neat): ν, = 3401, 2965, 2882, 1652, 1626, 1370, 1297, 
1072, 1017 cm−1. 1H NMR (500 MHz, MeOD) δ = 6.20 (d, J = 2.2 Hz, 
1H), 4.44 (dd, J = 10.4, 2.2 Hz, 1H), 3.86 (t, J = 2.9 Hz, 1H), 3.39 (dd, 
J = 10.3, 3.2 Hz, 1H), 2.98 (d, J = 13.6 Hz, 1H), 2.12 (d, J = 14.3 Hz, 
1H), 2.08 (d, J = 2.1 Hz, 3H), 1.89 (d, J = 1.4 Hz, 3H), 1.56 (qd, J = 
7.1, 2.7 Hz, 1H), 1.18 (d, J = 1.4 Hz, 3H), 1.17 (s, 3H). 13C NMR (126 
MHz, MeOD) δ = (126 MHz, MeOD) δ = 194.2, 171.3, 145.6, 128.6, 
124.2, 77.5, 75.6, 70.1, 44.7, 43.6, 43.1, 22.8, 22.4, 20.1, 12.1. HRMS 
(ESI) Exact mass calculated for C15H23O4+ [M+H]+: 267.15909, found: 
267.15899 and C15H22O4Na+ [M+Na]+: 289.14075, found: 289.14084. 
Supplementary Material 
Additional experimental information, 1H and 13C NMR spectra, HPLC 
chromatograms and CD spectra are given in the Supporting 
information for this article, available on the WWW under 
http://dx.doi.org/10.1002/MS-number. 
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